Word: cancerous
(lookup in dictionary)
(lookup stats)
Dates: during 1970-1979
Sort By: most recent first
(reverse)
...students planning the party are divided over the question of donating the profits from the party to the Jimmy Fund, which raises money for cancer research, Gerald F. Cox '80, another student planner, said yesterday...
...bold proposal. Dr. Jordan Gutterman of Houston's M.D. Anderson Hospital and Tumor Institute had applied to the American Cancer Society for a grant of more than a million dollars to buy interferon, a scarce and expensive substance that has shown promise in cancer research. To buttress his request, Gutterman reported that of ten advanced breast cancer patients he had treated with interferon, four had shown shrinkage of their widespread tumors. Those results, following encouraging news about interferon in animal and human tests by other researchers, seemed too compelling to ignore. Exceeding even Gutterman's expectations, the A.C.S. set aside...
Subsequently, other researchers learned that the protein had antitumor as well as antiviral properties. Though exactly how it works is still a mystery, interferon appears not only to block the uncontrolled cell division that is characteristic of cancer but also to stimulate the body's immune system to kill cancer cells. Interferon has another plus; apparently because it is produced in the body, it has none of the unpleasant and debilitating side effects that accompany conventional cancer chemotherapy...
Until that day comes, and indeed until and if the new tests of interferon demonstrate that it is truly effective, medical experts are warning cancer victims and their relatives against undue optimism Says A.C.S. official and former National Cancer Institute Director Frank J Rauscher Jr.: "Interferon is just one of thousands of substances being tested for antitumor activity. The only way to find out if interferon is any good is to buy the material and get the research started That's where we are today...
...Patients with advanced cases of certain cancers of the skin, bone, lymph system, breast, lung and bladder will receive interferon at Houston's M.D. Anderson; the Sloan-Kettering Institute for Cancer Research and the Columbia University College of Physicians and Surgeons, both in Manhattan; Buffalo's Roswell Park Memorial Institute; the Stanford University Medical Center in Palo Alto, Calif...